3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
Reports Fourth Quarter and Full Year 2025 Financial Results
Ligand Pharmaceuticals Announces Private Placement Investment in Athira Pharma
Reports Third Quarter 2025 Financial Results and Raises Guidance
News, Material Contracts
Announces Closing of Convertible Senior Notes Offering
Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030
Reports Second Quarter 2025 Financial Results and Raises Guidance
Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
FY 2024
Q3
Q2
Q1
FY 2023
S-3ASR
Registration Statement for Securities to be Offered to Employees
Prospectus Filed Pursuant to Rule 425
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Amended Notice of Proposed Sale of Securities